remotely heated to damage biological structures in close proximity. Targeting is typically accomplished by modifying the surface of the nanoparticle with a chemical or biological compound. They accumulate at tumor sites through Enhanced Permeability Retention (EPR), where the tumor vessels accelerate the delivery of the nanoparticles directly into the tumor. The porous shell of the silica allows control over the rate at which the drug diffuses out of the nanoparticle. The shell can be modified to have an affinity for the drug, or even to be triggered by pH, heat, light, salts, or other signaling molecules. Silica nanoparticles are also used in bio imaging because they can accommodate fluorescent/MRI/PET/ SPECT contrast agents and drug/DNA molecules to their adaptable surface and pores. This is made possible by using the silica nanoparticle as a vector for the expression of fluorescent proteins. Several different types of fluorescent probes, like cyanine dyes, methyl violegen, or semiconductor quantum dots can be conjugated to silica nanoparticles and delivered into specific cells or injected in vivo. Carrier molecule RGD peptide has been very useful of targeted in vivo imaging. Topically applied surface-enhanced resonance Raman ratiometric spectroscopy (TAS3RS)- TAS3RS is another technique that is starting to make advancement in the medical field. It is an imaging technique that uses Folate Receptors (FR) to detect tumor lesions as small as 370 micrometers. Folate Receptors are membrane bound surface proteins that bind folates and folate conjugates with high affinity. FR is frequently overexpressed in a number of human malignancies including cancer of the ovary, lung, kidney, breast, bladder, brain, and endometrium. Raman imaging is a type of spectroscopy that is used in chemistry to provide structural fingerprint by which molecules can be identified. It relies upon inelastic scattering of photons, which result in ultra high sensitivity. There was a study that was done where two different surface enhanced resonance Raman scattering were synthesized (SERRS). One of the SERRS was a “targeted nanoprobe functionalized with an anti-folate-receptor antibody (αFR-Ab) via a PEG-maleimide-succinimide and using the infrared dye IR780 as the Raman reporter, henceforth referred to as αFR-NP, and a nontargeted probe (nt-NP) coated with PEG5000-maleimide and featuring the IR140 infrared dye as the Raman reporter.” These two different mixtures were injected into tumor bearing mice and healthy controlled mice. The mice were imaged with Bioluminescence (BLI) signal that produces light energy within an organism's body. They were also scanned with the